SUMMARY Pancreatitis is seldom seen as a severe complication of renal transplantation. In a review on 1321 renal transplants, 23 cases with 12 deaths are reported (Johnson and Nabseth, 1970) . Single case reports may be added. In our departments pancreatitis has proved to be a fairly frequent complication. It developed in 10 (7 %) of 147 patients with renal transplantation one week to seven and a half years after transplantation (patients with primary hyperparathyroidism excluded). Three of the eight acute cases had haemorrhagic pancreatitis, in two of them leading to death. Two patients had chronic calcifying pancreatitis. Pancreatitis was complicated in one case by abscess formation and in two by severe haemorrhage into a pseudo-cyst. In two patients the diagnosis was made at necropsy only and death was probably not related to the acute pancreatitis. The exact pathogenesis of pancreatitis after renal transplantation cannot be precisely assessed. Possible contributing factors are treatment with corticosteroids, azathioprin, and L-asparaginase, early hypercalcaemia after transplantation, surgery, infections of bacterial or viral origin, and unknown immunological processes.
and postoperative treatment have already been described (Largiader, Linder, Senning, Scheitlin, Wegmann, and Van Rood, 1970) . To be included in the study, patients had to fulfil the following criteria: ACUTE PANCREATITIS Serum-amylase above 1000 Somogyi units (normal 40 to 160 SU) together with typical clinical symptoms, or anatomical evidence of acute pancreatitis at laparotomy or necropsy.
CHRONIC PANCREATITIS
Calcification in the pancreatic region on radiographs, or anatomical evidence of chronic pancreatitis at laparotomy or necropsy, or repeatedly decreased faecal concentrations of chymotrypsin and trypsin.
As most patients had impaired renal function at the time of diagnosis, the urinary amylase concentration was not considered diagnostic. Patients with moderate and transient hyperamylassaemia (Penn et al, 1972) , who usually had none of the typical symptoms of acute pancreatitis, were not included in the study. The quantitative estimation of pancreatic function by stimulation with pancreozymin and secretin could be performed in one case only. The faecal enzyme concentration was determined in all surviving patients. (1963) and by Reynolds (1958) .
Discussion
As serum amylase and lipase determinations are not routinely performed in transplanted patients, the true incidence of pancreatitis is not known. The frequency of pancreatitis was 7% in this study and corresponds to that of 5-6y% reported by Penn et al (1972) . Johnson and Nabseth (1970) report an incidence of 1-7y% among 1321 transplant patients.
The relatively high incidence in our series may partly be explained by the two cases detected only at necropsy and the two patients with chronic calcifying pancreatitis. No such cases are included in the literature. The mortality of 20% in the present series seems to be somewhat lower than the mortality of 50 to 60% found by other authors. But the difference should not be overemphasized as the number of pancreatitis patients is small in all series.
Possible Aetiological Factors
The aetiology of pancreatitis in patients with renal transplantation varies. In addition to the common causes, contributing causes such as acute or chronic rejection, continuous immunosuppression, impaired response to infections, as well as the use of various drugs have to be considered.
Gallstones were present in one patient only (case 10). As chronic calcifying pancreatitis with pseudocyst followed cholecystectomy and revision of the common bile duct and repeated cholangiography gave no evidence of a remaining stone in the common duct, gallstones are not very likely to be the cause of this case of chronic pancreatitis (Ammann, Akovbiantz, Deyhle, Hahnloser, Largiader, and Wellauer, 1974) . Another patient (case 5) had cholecystectomy with revision of the common bile duct because of asymptomatic gallstones three years before transplantation. The patient has refused cholangiography at the present time, so that a common duct stone cannot be excluded, but clinical and biochemical evidence did not support this possibility.
None of our patients had a history of chronic or excessive alcohol intake.
Operations, especially in the upper abdomen, including nephrectomy, can be the cause of damage to the pancreas and of acute pancreatitis (Dunphy, Brooks, and Ackroyd, 1953; Starzl and Porter, 1967; Van Geertruyden and Toussaint, 1967; Penn et al, 1972) . In two of our patients the interval between operation and the onset of acute pancreatitis was very short, thus favouring this pathogenesis.
There were no cases of malignant hypertension; three patients showed moderately increased blood pressure, which is not thought to have contributed to the development of acute pancreatitis.
Hypercalcaemia as a possible cause of acute pancreatitis developed in two patients after transplantation (cases 4 and 8). Hyperlipaemia was not present in any of the patients. Uraemia predisposes to pancreatitis. The cause is unknown (Merrill and Hampers, 1970) . Four of our patients had urea values of above 16-6 mmol/l. Serum creatinine was normal in only three cases. It is thus possible that impaired renal function contributed to the development of either acute or chronic pancreatitis.
Corticosteroids are accepted as a cause of pancreatitis (Lazarus and Bencosme, 1956; Stumpf, Wilens, and Somoza, 1956; Baar and Wolff, 1957; Carone and Liebow, 1957; Oppenheimer and Boitnott, 1960; Dreiling, Janowitz, and Perrier, 1964) . All patients were on this drug when they developed pancreatitis. Furthermore pancreatitis occurred in three patients simultaneously with the increase of the dosage of corticosteroids for the treatment of acute rejection and in two cases immediately after instituting immunosuppressive treatment after transplantation. It is suggested therefore that corticosteroids may be an important aetiological factor in posttransplantation pancreatitis. The pathogenesis of corticosteroid-induced pancreatitis is not clear. Since aseptic bone necrosis (Cruess, Blennerhassett, Macdonald, Maclean, and Dossetor, 1968 ; Briggs, Hampers, Merrill, Hager, Wilson, Birtch, and Murray, 1972) , another well known complication of corticosteroid treatment in renal transplantation, is thought to be due to occlusive vascular processes, the same cause might contribute to the pathogenesis of pancreatitis. But in this series only case 2 had concomitant aseptic bone necrosis. All patients had azathioprin. Only a few reports exist on the relationship between acute pancreatitis and this drug. Nogueira and Freedman (1972) report one patient with regional enteritis in whom acute pancreatitis developed at the time the azathioprin treatment was started. Another episode of pancreatitis occurred after challenge with azathioprin. A similar case was reported by Kawanishi, Rudolph, and Bull (1972) . The role of azathioprin in acute pancreatitis after renal transplantation is also discussed by Hume (1966) .
Antilymphocytic globulin is not known to cause pancreatitis. In our series five patients had never had antilymphocytic globulin whereas four were treated with this serum throughout the attack of pancreatitis. L-asparaginase has been incriminated as a cause of acute pancreatitis (Shaw, Barnes, Madden, and Bagshawe, 1970) . Only one of our patients was given this drug for severe rejection before pancreatitis developed. In the earlier days of renal transplantation we frequently administered L-asparaginase without noticing pancreatic complications. Some patients were receiving other drugs at the time or shortly beforepancreatitis but none of these is known to cause pancreatitis.
Infections of bacterial and viral origin are frequent in patients receiving immunosuppressive drugs. A pathogenetic role of infective agents, especially of cytomegalic virus, has been raised in acute pancreatitis (Van Geertruyden and Toussaint, 1967; Johnson and Nabseth, 1970; Penn et al, 1972) . Cytomegaly was not found in the necropsy material investigated. The serological titres assessed in two patients were negative. In two other patients who died after renal transplantation cytomegalic inclusion bodies were found in pancreatic cells without any histological signs of acute pancreatitis. Cases 1 and 8 had severe bacterial infections at the time of pancreatitis.
Hepatitis B-antigen was positive in one of eight patients at the time of pancreatitis; in another it became positive six months after pancreatitis. Hepatitis-B-antigen has been incriminated in periarteritis nodosa (Baker, Kaplan, Benz, Sidel, and Wolfe, 1972) . A similar immunological mechanism could be responsible for the development of pancreatitis. There were no other signs favouring the diagnosis of periarteritis nodosa in these patients, however. Other immunological mechanisms have to be considered. Cross-reactingantibodiesaresuggested to damage the renal transplant and the organs of the receptor (Fujii and Nelson, 1963) . It might further be speculated that unknown protective mechanisms, which prevent the pancreas from autodigestion, are depressed by immunosuppressive drugs.
In conclusion, it is not possible to find a single factor responsible for the frequency of pancreatitis after renal transplantation. Certain factors, such as immunological processes, the administration of corticosteroids and azathioprin, are present in all cases and various other contributing factors are usually present. The institution of corticosteroid therapy or the increase of corticosteroid dosage may play an important aetiological part. Prevention of pancreatitis should be attempted by careful surgery, omission of L-asparaginase, the prevention of posttransplant hypercalcaemia, the prescription of the lowest possible dose of corticosteroids, prompt and adequate treatment of rejection, and a vigorous approach to infections. transplantation. 
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